KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Net Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Net Margin for 17 consecutive years, with 103.87% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 21111.0% to 103.87% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.42%, a 10128.0% increase, with the full-year FY2025 number at 29.42%, up 10127.0% from a year prior.
  • Net Margin was 103.87% for Q4 2025 at Bio-Rad Laboratories, up from 52.36% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 525.84% in Q3 2021 to a low of 480.98% in Q1 2022.
  • A 5-year average of 10.77% and a median of 13.87% in 2023 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: tumbled -61546bps in 2022, then surged 49116bps in 2023.
  • Bio-Rad Laboratories' Net Margin stood at 213.61% in 2021, then skyrocketed by 153bps to 113.35% in 2022, then crashed by -55bps to 51.34% in 2023, then tumbled by -309bps to 107.24% in 2024, then soared by 197bps to 103.87% in 2025.
  • Per Business Quant, the three most recent readings for BIO's Net Margin are 103.87% (Q4 2025), 52.36% (Q3 2025), and 48.77% (Q2 2025).